Design of Glucagon-Like Peptide-1 Receptor Agonist for Diabetes Mellitus from Traditional Chinese Medicine

<table>Disorder disposition of GLP1 receptor structure. The most common key residues for all the 3 compounds are in the nondisordered region (below the red line).</table>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: Design of Glucagon-Like Peptide-1 Receptor Agonist for Diabetes Mellitus from Traditional Chinese Medicine 